멀티플렉스 어세이 시장 규모, 점유율, 성장 분석 : 제품 유형별, 유형별, 기술별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Multiplex Assay Market Size, Share, and Growth Analysis, By Product Type (Consumables, Instruments), By Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assays), By Technology, By Application, By End-User, By Region - Industry Forecast 2025-2032
상품코드:1673585
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
멀티플렉스 분석 시장 규모는 2023년 37억 달러, 2024년 40억 5,000만 달러에서 2032년에는 83억 7,000만 달러로 성장하고, 예측 기간(2025-2032년) 동안 9.5%의 연평균 복합 성장률(CAGR)을 보일 것으로 예상됩니다.
세계 멀티플렉스 분석 시장은 만성 질환 및 감염성 질환의 유병률 증가와 기존 방법 대비 멀티플렉스 분석의 장점으로 인해 크게 성장하고 있습니다. dMMR 고형암 식별을 위한 Roche와 같은 FDA 승인과 같은 동반 진단 약물의 사용이 증가하고 있으며, 이는 이 분야의 미래가 유망하다는 것을 증명합니다. 비소세포폐암과 같은 암의 생존율을 3배까지 높일 수 있는 조기 진단은 시장 확대 가능성을 더욱 강조하고 있습니다. 또한, 바이오마커 검증 및 자동화 시스템에 대한 수요가 증가하면서 하이스루풋 분석의 필요성이 높아지고 있습니다. 암, 자가면역질환, 신경퇴행성 질환 등 다양한 용도에 대응하는 멀티플렉스 어세이는 조기 발견과 인지도를 높이는데 매우 중요하며, 궁극적으로 시장 성장의 원동력이 될 것입니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
기술 진보
멀티플렉스 어세이 시장 규모 : 제품 유형별&CAGR(2025-2032년)
시장 개요
소모품
기기
소프트웨어
멀티플렉스 어세이 시장 규모 : 유형별&CAGR(2025-2032년)
시장 개요
단백질 멀티플렉스 어세이
평면 단백질 어세이
비즈 기반 단백질 어세이
기타
핵산 멀티플렉스 어세이
평면 핵산 어세이
비즈 기반 핵산 어세이
기타
세포 기반 멀티플렉스 어세이
멀티플렉스 어세이 시장 규모 : 기술별&CAGR(2025-2032년)
시장 개요
유세포 분석기
형광 감지
발광
멀티플렉스 실시간 PCR
기타
멀티플렉스 어세이 시장 규모 : 용도별&CAGR(2025-2032년)
시장 개요
연구개발
Drug Discovery & Development
바이오마커 발견 및 검증
임상 진단
감염증
암
심혈관 질환
자가면역 질환
신경계 질환
대사 및 내분비 질환
기타 병
멀티플렉스 어세이 시장 규모 : 최종사용자별&CAGR(2025-2032년)
시장 개요
제약 기업 및 바이오테크놀러지 기업
병원 및 연구기관
참조 실험실
기타
멀티플렉스 어세이 시장 규모 : 지역별&CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
전년대비 매출 비교(2022-2024년)
주요 기업 개요
Lonza Group(Switzerland)
DiaSorin(Italy)
WuXi Biologics(China)
Seegene(South Korea)
Ayoxxa Biosystems(Germany)
Thermo Fisher Scientific(United States)
Bio-Rad Laboratories(United States)
Luminex Corporation(United States)
QIAGEN(Germany)
Illumina(United States)
Agilent Technologies(United States)
PerkinElmer(United States)
Merck KGaA(Germany)
Becton, Dickinson and Company(United States)
Roche Diagnostics(Switzerland)
Siemens Healthineers(Germany)
Danaher Corporation(United States)
Abbott Laboratories(United States)
Meso Scale Diagnostics(United States)
Quanterix Corporation(United States)
결론과 제안
LSH
영문 목차
영문목차
Multiplex Assay Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 4.05 billion in 2024 to USD 8.37 billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).
The global multiplex assay market is experiencing significant growth driven by the increasing prevalence of chronic and infectious diseases and the advantages of multiplex assays over traditional methods. The rising utilization in companion diagnostics is particularly noteworthy, as evidenced by FDA approvals like Roche's for identifying dMMR solid tumors, indicating a promising future for this sector. Early disease diagnosis, which can triple survival rates for cancers such as non-small cell lung cancer, further emphasizes the market's expansion potential. Additionally, the validation of biomarkers and demand for automated systems bolster the need for high-throughput assays. With applications spanning cancer, autoimmune diseases, and neurodegenerative disorders, multiplex assays are pivotal in enhancing early detection and raising awareness, ultimately fueling market growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Multiplex Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Multiplex Assay Market Segments Analysis
Global Multiplex Assay Market is segmented by Product Type, Type, Technology, Application, End-User and region. Based on Product Type, the market is segmented into Consumables, Instruments and Software. Based on Type, the market is segmented into Protein Multiplex Assays, Nucleic Acid Multiplex Assays and Cell-based Multiplex Assays. Based on Technology, the market is segmented into Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-time PCR and Others. Based on Application, the market is segmented into Research & Development and Clinical Diagnostics. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Multiplex Assay Market
The increasing emphasis on personalized medicine is significantly fueling the growth of the multiplex assay market. These assays facilitate the simultaneous analysis of several biomarkers, which enhances patient stratification and leads to more tailored treatment options. By enabling healthcare providers to assess multiple health indicators at once, multiplex assays contribute to more accurate diagnoses and effective therapeutic strategies. This capability not only optimizes patient care but also supports the shift towards individualized therapies that cater to specific patient needs, thus reinforcing the demand for these advanced diagnostic tools in clinical settings.
Restraints in the Multiplex Assay Market
The multiplex assay market faces significant restraints primarily due to regulatory challenges that can hinder their widespread adoption. The complex nature of these assays necessitates obtaining regulatory approval, a process that is often time-consuming and financially burdensome. Such stringent requirements can deter manufacturers from developing and introducing new multiplex assays into the market, ultimately slowing innovation and limiting the availability of these advanced diagnostic tools. Consequently, the lengthy regulatory procedures may restrict market growth and access to potentially valuable multiplex assays that could significantly enhance diagnostic accuracy and efficiency across various medical applications.
Market Trends of the Multiplex Assay Market
The multiplex assay market is witnessing a significant trend towards the adoption of multiplex immunoassays, driven by their efficiency in measuring multiple protein targets within a single sample. This capability not only streamlines workflows but also enhances the accuracy and throughput of diagnostic testing, drug discovery, and biomarker identification processes. As healthcare continues to shift towards personalized medicine and more precise diagnostics, the demand for these assays is expected to grow steadily. Furthermore, advancements in technology that facilitate higher sensitivity and multiplexing capabilities are propelling market growth, positioning multiplex immunoassays as essential tools in clinical research and therapeutics.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Global Multiplex Assay Market Size by Product Type & CAGR (2025-2032)
Market Overview
Consumables
Instruments
Software
Global Multiplex Assay Market Size by Type & CAGR (2025-2032)
Market Overview
Protein Multiplex Assays
Planar Protein Assays
Bead-based Protein Assays
Others
Nucleic Acid Multiplex Assays
Planar Nucleic Acid Assays
Bead-based Nucleic Acid Assays
Others
Cell-based Multiplex Assays
Global Multiplex Assay Market Size by Technology & CAGR (2025-2032)
Market Overview
Flow Cytometry
Fluorescence Detection
Luminescence
Multiplex Real-time PCR
Others
Global Multiplex Assay Market Size by Application & CAGR (2025-2032)
Market Overview
Research & Development
Drug Discovery & Development
Biomarker Discovery & Validation
Clinical Diagnostics
Infectious Diseases
Cancer
Cardiovascular Diseases
Autoimmune Diseases
Nervous System Disorders
Metabolism & Endocrinology Disorders
Other Diseases
Global Multiplex Assay Market Size by End-User & CAGR (2025-2032)
Market Overview
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Others
Global Multiplex Assay Market Size & CAGR (2025-2032)
North America (Product Type, Type, Technology, Application, End-User)
US
Canada
Europe (Product Type, Type, Technology, Application, End-User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product Type, Type, Technology, Application, End-User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product Type, Type, Technology, Application, End-User)
Brazil
Rest of Latin America
Middle East & Africa (Product Type, Type, Technology, Application, End-User)
